Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention

Table 5 Medication use rate in patients with known coronary artery disease (%)

Medications	Total	Male	Female	P value
	n = 687	n = 516	n = 171
Antiplatelets	84.6	85.3	82.5	0.377
Beta blockers	53.3	55.2	47.4	0.074
ACE inhibitors	51.2	49.0	57.9	0.044
Ca antagonists	29.3	28.7	31.0	0.565
ARB-s	6.0	5.8	6.4	0.767
Diuretics	22.3	20.5	27.5	0.059
Other antihypertensives	2.3	1.9	3.5	0.238
Nitrates	21.3	7.6	62.6	< 0.00001
Insulin	7.6	6.4	11.1	0.043
Oral hypoglycaemics	23	20.9	29.2	0.025
Statins	73.9	76.4	66.7	0.012
Other lipid lowering	1.3	1.2	1.8	0.555

Ca: Calcium; ACE: Angiotensin converting enzyme; ARB: Angiotensin receptor blocker. P value represents differences by sex.